41
Participants
Start Date
March 31, 1999
trastuzumab
gemcitabine hydrochloride
Memorial Sloan-Kettering Cancer Center, New York
Mount Sinai Medical Center, NY, New York
Rush-Presbyterian-St. Luke's Medical Center, Chicago
New England Medical Center Hospital, Boston
St. Elizabeth's Medical Center, Boston
Cancer Institute of New Jersey, New Brunswick
University of Pittsburgh Cancer Institute, Pittsburgh
Memorial Hospital of Rhode Island, Pawtucket
Rhode Island Hospital, Providence
Roger Williams Medical Center/BUSM, Providence
Brown University Oncology Group, Providence
University of Texas - MD Anderson Cancer Center, Houston
Lead Sponsor
National Cancer Institute (NCI)
NIH
Brown University
OTHER